▶ 調査レポート

生物学的治療薬のアジア市場:市場規模・シェア・価格・動向・予測

• 英文タイトル:Asia Pacific Biologic Therapeutics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Prof Researchが調査・発行した産業分析レポートです。生物学的治療薬のアジア市場:市場規模・シェア・価格・動向・予測 / Asia Pacific Biologic Therapeutics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast / D0FB0648182資料のイメージです。• レポートコード:D0FB0648182
• 出版社/出版日:Prof Research / 2019年12月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、140ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥420,000 (USD3,000)▷ お問い合わせ
  Site License¥532,000 (USD3,800)▷ お問い合わせ
  Global Site License¥700,000 (USD5,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
生物学的治療薬のアジア太平洋市場規模は2014~2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019~2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は生物学的治療薬の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける生物学的治療薬市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。
・市場概要
・産業チェーン分析(ファイブフォース分析、コスト構造分析)
・市場動向
・生物学的治療薬のアジア市場規模推移2014-2019
・生物学的治療薬のアジア市場規模予測2019-2024
・生物学的治療薬のサプライヤー分析
・顧客(需要先)分析
・主要企業分析(Pfizer、Novartis Global、AstraZeneca、Merck、GlaxoSmithKline、Aurobindo Pharma)
・結論

Abstract:

The Asia Pacific Biologic Therapeutics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.

This report is an essential reference for who looks for detailed information on Asia Pacific Biologic Therapeutics market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Biologic Therapeutics market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.

Key Points of this Report:

* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Biologic Therapeutics
* It describes present situation, historical background and future forecast
* Comprehensive data showing Biologic Therapeutics capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Biologic Therapeutics manufacturers
* Biologic Therapeutics market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us

The largest vendors of Asia Pacific Biologic Therapeutics market: (At least 6 companies included)
* Pfizer
* Novartis Global
* AstraZeneca
* Merck
* GlaxoSmithKline
* Aurobindo Pharma

The Biologic Therapeutics market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand

The reports analysis Biologic Therapeutics market in Asia Pacific by products type:
* Type I
* Type II
* Type III

The reports analysis Biologic Therapeutics market in Asia Pacific by application as well:
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

Table of Contents

Chapter One Biologic Therapeutics Overview
1.1 Biologic Therapeutics Outline
1.2 Classification and Application
1.3 Manufacturing Technology

Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis

Chapter Three Market Dynamics of Biologic Therapeutics Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges

Chapter Four Asia Pacific Market of Biologic Therapeutics (2014-2019)
4.1 Biologic Therapeutics Supply
4.2 Biologic Therapeutics Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis

Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Biologic Therapeutics Supply
5.2 Biologic Therapeutics Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis

Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation

Chapter Seven Asia Pacific Biologic Therapeutics Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis

Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Pfizer
8.2 Novartis Global
8.3 AstraZeneca
8.4 Merck
8.5 GlaxoSmithKline
……
……

Chapter Nine Research Conclusions of Asia Pacific Biologic Therapeutics Industry

Tables and Figures

Figure Commercial Product of Biologic Therapeutics
Table Classification of Biologic Therapeutics
Table Application of Biologic Therapeutics
Figure Porter Five Forces Model Analysis of Asia Pacific Biologic Therapeutics
Figure Production Cost Analysis of Asia Pacific Biologic Therapeutics
Table Biologic Therapeutics Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Biologic Therapeutics Capacity List
Table 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Production List
Table 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Biologic Therapeutics Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Biologic Therapeutics Production Value and Growth Rate
Table 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Biologic Therapeutics Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Biologic Therapeutics
Table 2014-2019 Asia Pacific Import and Export of Biologic Therapeutics
Table 2014-2019 Asia Pacific Biologic Therapeutics Demand List by Application
Figure 2014-2019 Asia Pacific Biologic Therapeutics Demand by Application
Table 2014-2019 Asia Pacific Biologic Therapeutics Demand Share List by Application
Figure 2014-2019 Asia Pacific Biologic Therapeutics Demand Share by Application
Table 2014-2019 Asia Pacific Biologic Therapeutics Country-wise Consumption List
Figure 2014-2019 Asia Pacific Biologic Therapeutics Country-wise Consumption
Table 2014-2019 Asia Pacific Biologic Therapeutics Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Biologic Therapeutics Country-wise Consumption Share
Table 2014-2019 Asia Pacific Biologic Therapeutics Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Biologic Therapeutics Capacity List
Table 2019-2024 Asia Pacific Biologic Therapeutics Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Biologic Therapeutics Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Biologic Therapeutics Key Manufacturers Production List
Table 2019-2024 Asia Pacific Biologic Therapeutics Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Biologic Therapeutics Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Biologic Therapeutics Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Biologic Therapeutics Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Biologic Therapeutics
Table 2019-2024 Asia Pacific Import and Export of Biologic Therapeutics
Table 2019-2024 Asia Pacific Demand of Biologic Therapeutics by Application
Figure 2019-2024 Asia Pacific Biologic Therapeutics Demand by Application
Table 2019-2024 Asia Pacific Biologic Therapeutics Demand Share List by Application
Figure 2019-2024 Asia Pacific Biologic Therapeutics Demand Share by Application
Table 2019-2024 Asia Pacific Biologic Therapeutics Country-wise Consumption List
Figure 2019-2024 Asia Pacific Biologic Therapeutics Country-wise Consumption
Table 2019-2024 Asia Pacific Biologic Therapeutics Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Biologic Therapeutics Country-wise Consumption Share
Table 2019-2024 Asia Pacific Biologic Therapeutics Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Biologic Therapeutics Raw Material Suppliers
Table Key End Users List
Table Profile of Pfizer
Table SWOT Analysis of Pfizer
Table Pfizer Biologic Therapeutics Product Specification
Table 2014-2019 Pfizer Biologic Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Pfizer Biologic Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Pfizer Biologic Therapeutics Production Global Market Share
Table SWOT Analysis of Novartis Global
Figure Novartis Global Biologic Therapeutics Products
Table 2014-2019 Novartis Global Biologic Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Novartis Global Biologic Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Novartis Global Biologic Therapeutics Production Global Market Share
Table SWOT Analysis of AstraZeneca
Figure AstraZeneca Biologic Therapeutics Product
Table AstraZeneca Biologic Therapeutics Product Specification
Table 2014-2019 AstraZeneca Biologic Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 AstraZeneca Biologic Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 AstraZeneca Biologic Therapeutics Production Global Market Share
Table Profile of Merck
Table SWOT Analysis of Merck
Figure Merck Biologic Therapeutics Product
Table Merck Biologic Therapeutics Product Specification
Table 2014-2019 Merck Biologic Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Merck Biologic Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Merck Biologic Therapeutics Production Global Market Share
Table Profile of GlaxoSmithKline
Table SWOT Analysis of GlaxoSmithKline
Figure GlaxoSmithKline Biologic Therapeutics Product
Table 2014-2019 GlaxoSmithKline Biologic Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 GlaxoSmithKline Biologic Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 GlaxoSmithKline Biologic Therapeutics Production Global Market Share
……
……